CAS: 39827-11-7; Benzo[b]Thiophene-2-Carbonyl Chloride

该化合物是一种有机化合物,其特点是其独特的结构,其特征是附于氯碳基功能组的苯并[b]硫苯,该化合物一般看起来无色可粉色黄色液体或固体,视其纯度和具体条件而定,以其反应性而著称,特别是由于氯碳基组的存在,它可以参与核循环替代反应,使其在有机合成中有用.该化合物经常被用作各种制药和农用化学品合成的中间体.其分子结构有助于其特性,包括其有机溶剂中的溶性及其在某些条件下的稳定性.然而,重要的是要谨慎地处理该化合物,因为碳基氯化物可以是腐蚀性的,并可能在水解过程中释放有害气体.在实验室环境中与该物质打交道时,应当注意适当的安全措施.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

苯并噻吩-2-羧酸 Benzo[b]Thiophene-2-Carboxylic Acid 6314-28-9

合成工艺路线路线简述

    苯并噻吩-2-羧酸置于氯化亚砜体系中,化学反应生成 苯并噻吩-2-羰酰氯
    参考文献:Novel Methylselenoesters As Antiproliferative Agents
    标题:Novel Methylselenoesters As Antiproliferative Agents
    摘要:硒(se)化合物在癌症治疗中具有潜在的治疗作用.重要的是,硒化合物的生物效应是通过其代谢产物发挥的,其中甲基硒醇(ch3Seh)是一个关键的执行者.在本研究中,我们开发了一系列具有不同骨架的甲基硒酯,旨在调节ch3Seh的释放.这十五种化合物遵循lipinski的五规则,并且除了化合物1和14外,其药物相似性值均优于阳性对照甲基硒酸.对这些化合物进行了自由基清除活性评估,其中化合物11能减少dpph和abts自由基.在五种癌细胞系(前列腺,结肠和肺癌,乳腺腺癌和慢性髓性白血病)和两种非恶性细胞系(肺和乳腺上皮)中评估了这些化合物的细胞毒性.十种化合物在72小时内在四种癌细胞系中gi50值低于10 μm.由于与甲基硒酸的相似性,化合物5和15被选为进一步在乳腺腺癌细胞系中进行作用机制表征.这两种化合物均诱导g2/m期阻滞,而细胞死亡部分通过caspase介导.还研究了它们的还原和代谢,这两种化合物都被证明是还原型酶硫氧还蛋白还原酶的底物.
    DOI:10.3390/molecules22081288

    海关参考信息

    专利信息


    专利号:EP-2918579-A1
    优先权日:2014-03-14
    标题 :Synthesis of 2-arylmethyl-5-aryl-thiophene
    权利人:LEK PHARMACEUTICALS
    摘要:The present invention provides a new synthetic process for the production of 2-arylmethyl-5-aryl-thiophene, an intermediate in the synthesis of C-aryl glycosides.

    专利号:US-6664410-B1
    优先权日:1999-07-15
    标题 :Solid phase nitrile synthesis
    发明人:KOBYLECKI RYSZARD; HONE NEAL DAVID; PAYNE LLOYD JAMES
    权利人:MILLENNIUM PHARMACEUTICALS LTD
    摘要:A nitrile compound is prepared by treating a solid supported amide to dehydrate it and cleave it from the support in one operation. The preparation involves acetylation of the amide compound in the presence of a base at a temperature of less than 100° C.

    专利号:EP-0731800-A1
    优先权日:1993-12-03
    标题:IMPROVED PROCESS FOR THE SYNTHESIS OF 3-CHLOROBENZO [b]THIOPHENE-2-CARBONYL CHLORIDES

    专利号:US-7250410-B2
    优先权日:2001-06-07
    标题:Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
    发明人:BOURGUIGNON JEAN-JACQUES; LAGOUGE YAN; LUGNIER CLAIRE; KLOTZ EVELINE; MACHER JEAN-PAUL; RABOISSON PIERRE; SCHULTZ DOMINIQUE
    权利人:VIA PHARMACEUTICALS INC
    摘要:The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates. The inventive compounds more particularly correspond to general formula (I):

    专利号:US-8242142-B2
    优先权日:2008-08-19
    标题:Cyclohexylamines, phenylamines and uses thereof
    发明人:LIN SHUO; YANG ZHEN
    权利人:LIN SHUO; YANG ZHEN; UNIV CALIFORNIA; UNIV PEKING SHENZHEN GRAD SCHO
    摘要:Compounds having the formula I, their methods of synthesis, and pharmaceutically acceptable salts of certain of them are provided in which the variables have the definitions described herein. n n n n n n n n n n Compositions including the compounds having the formula I-A in which the variables have the definitions described herein, and methods of using the compositions for the treatment of certain diseases mediated by the up-regulation of Smo are also disclosed.

    专利号:US-7648986-B2
    优先权日:2002-01-10
    标题:Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors
    发明人:NAGARATHNAM DHANAPALAN; KHIRE UDAY; ASGARI DAVOUD; SHAO JIANXING; LIU XIAO-GAO; WANG CHUNGUANG; HART BARRY; WEBER OLAF; LYNCH MARK; ZHANG LEI; WANG LEI
    权利人:BAYER HEALTHCARE LLC
    摘要:Disclosed are compounds and derivatives thereof their synthesis, and their use as Rho-kinase inhibitors. These compounds of the present invention are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease.
    南京新斯特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nstbio.com
    企业联系电话:025-85331029,18915981017👤
    📞南京新斯特生物科技有限公司 ⚠️参考联系方式
    联系人:杨女士
    电话:025-85331029,18915981017
    手机:18915981017
    传真:025-85331829
    邮箱:sales@nstbio.com
    通信地址: 江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    邮编: 210010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Ley, S. V.; Browne, D. L.; OʼBrien, M., Science of Synthesis: Flow Chemistry in Organic Synthesis, (2018) 1, 277.
    摘要:Wu, S.; Song, H.; Hu, M., Science of Synthesis: Modern Strategies in Organofluorine Chemistry , (2024) 1, 49.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知